AETHLON MEDICAL, INC. Repayments of Convertible Debt
AETHLON MEDICAL, INC. (AEMD) reported Repayments of Convertible Debt of $992.59 thousand for the 12-month period ending 2021-03-31, per its 10-K filed 2021-06-24.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfConvertibleDebt · last filed 2021-06-24
- AETHLON MEDICAL, INC. repayments of convertible debt for the quarter ending 2021-03-31 was $992.59K.
- AETHLON MEDICAL, INC. repayments of convertible debt for the quarter ending 2020-12-31 was $0.00.
- AETHLON MEDICAL, INC. repayments of convertible debt for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
- AETHLON MEDICAL, INC. repayments of convertible debt for the quarter ending 2020-06-30 was $0.00, a 100.00% decline year-over-year.
- AETHLON MEDICAL, INC. repayments of convertible debt for fiscal 2021 was $992.59K, a 0.00% change from fiscal 2020.
- AETHLON MEDICAL, INC. repayments of convertible debt for fiscal 2020 was $992.59K.
| Period end | Repayments of Convertible Debt 3 month | Repayments of Convertible Debt 6 month | Repayments of Convertible Debt 9 month | Repayments of Convertible Debt 12 month |
|---|---|---|---|---|
| 2021-03-31 | $992.59K derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-24 | $992.59K derived: sum of 2 quarters · filed 2021-06-24 | $992.59K derived: sum of 3 quarters · filed 2021-06-24 | $992.59K 10-K · filed 2021-06-24 |
| 2020-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-10 | $0.00 derived: sum of 2 quarters · filed 2021-02-10 | $0.00 10-Q · filed 2021-02-10 | $0.00 derived: sum of 4 quarters · filed 2021-02-10 |
| 2020-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-10-28 | $0.00 10-Q · filed 2020-10-28 | $0.00 derived: sum of 3 quarters · filed 2020-10-28 | $0.00 derived: sum of 4 quarters · filed 2021-02-10 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-11 | $0.00 derived: sum of 2 quarters · filed 2020-08-11 | $0.00 derived: sum of 3 quarters · filed 2021-02-10 | $892.59K derived: sum of 4 quarters · filed 2021-02-10 |
| 2020-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-25 | $0.00 derived: sum of 2 quarters · filed 2021-02-10 | $892.59K derived: sum of 3 quarters · filed 2021-02-10 | $992.59K 10-K · filed 2020-06-25 |
| 2019-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-10 | $892.59K derived: sum of 2 quarters · filed 2021-02-10 | $992.59K 10-Q · filed 2021-02-10 | |
| 2019-09-30 | $892.59K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-10-28 | $992.59K 10-Q · filed 2020-10-28 | ||
| 2019-06-30 | $100.00K 10-Q · filed 2020-08-11 | |||
| 2018-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-10 | $0.00 derived: sum of 2 quarters · filed 2020-02-10 | $0.00 10-Q · filed 2020-02-10 | |
| 2018-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-01 | $0.00 10-Q · filed 2019-11-01 | ||
| 2018-06-30 | $0.00 10-Q · filed 2019-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |